β-Adrenergic Blocking Agents in Patients With Diabetes—Friend and Foe

This publication has 21 references indexed in Scilit:

• Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease
  The American Journal of Cardiology, 1996
• Is There a Role for Beta‐blockers in Hypertensive Diabetic Patients?
  Diabetic Medicine, 1994
• Hypertension in the person with diabetes
  The Lancet Healthy Longevity, 1989
• Vasodilating Mechanism and Response to Physiological Pressor Stimuli of Acute Doses of Carvedilol Compared with Labetalol, Propranolol and Hydralazine
  Drugs, 1988
• PLACEBO-CONTROLLED COMPARISON OF CAPTOPRIL, ATENOLOL, LABETALOL, AND PINDOLOL IN HYPERTENSION COMPLICATED BY INTERMITTENT CLAUDICATION
  The Lancet, 1987
• AGGRAVATION BY PROPRANOLOL OF HYPERGLYCAEMIC EFFECT OF HYDROCHLOROTHIAZIDE IN TYPE II DIABETICS WITHOUT ALTERATION OF INSULIN SECRETION
  The Lancet, 1985
• Oral Propranolol and Metoprolol Both Impair Glucose Recovery from Insulin-induced Hypoglycemia in Insulin-dependent Diabetes Mellitus
  Diabetes Care, 1984
• Diuretic therapy for mild hypertension: The “real” cost of treatment
  The American Journal of Cardiology, 1984
• Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial Infarction
  New England Journal of Medicine, 1981
• Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.
  BMJ, 1977